Vai offline con l'app Player FM !
Advancing Medicine With Placenta-Derived Cells with Dr. Robert Hariri
Manage episode 434383124 series 2296270
🎙ABOUT DR. ROBERT HARIRI:
Dr. Bob Hariri is a pioneering surgeon, biomedical scientist, and serial entrepreneur with expertise in biomedicine and aerospace. He is the founder, chairperson, and CEO of Celularity, Inc., a leader in human cellular therapeutics, and previously founded Anthrogenesis Corporation, which was acquired by Celgene, where he served as CEO of Celgene Cellular Therapeutics.
He also co-founded Human Longevity, Inc. Dr. Hariri is renowned for pioneering the use of stem cells in treating life-threatening diseases, including the discovery of pluripotent stem cells from the human placenta. His innovations have led to over 170 patents and numerous accolades, including the Pontifical Medal for Innovation and the Thomas Alva Edison Award.
He is an Adjunct Professor of Neurosurgery at Weill Cornell Medical College and serves on various prestigious boards, including the Liberty Science Center and the X PRIZE Foundation. Beyond his medical and scientific contributions, Dr. Hariri is an accomplished jet-rated pilot and film producer.
🎙 ABOUT JOHN MARCHICA, HOST OF HEALTH CARE ROUNDS:
John Marchica is a veteran health care strategist and CEO of Darwin Research Group, a strategic consulting and market intelligence firm focused on hospitals, health systems, physician groups, and the evolving health care ecosystem. John has a degree in economics from Knox College, an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.
CONNECT WITH US:
🌐 Follow Health Care Rounds on LinkedIn
🌐 Follow Darwin Research Group on LinkedIn
📺 Watch Health Care Rounds of YouTube⚙️ Health Care Rounds is produced by Grippi Media
174 episodi
Manage episode 434383124 series 2296270
🎙ABOUT DR. ROBERT HARIRI:
Dr. Bob Hariri is a pioneering surgeon, biomedical scientist, and serial entrepreneur with expertise in biomedicine and aerospace. He is the founder, chairperson, and CEO of Celularity, Inc., a leader in human cellular therapeutics, and previously founded Anthrogenesis Corporation, which was acquired by Celgene, where he served as CEO of Celgene Cellular Therapeutics.
He also co-founded Human Longevity, Inc. Dr. Hariri is renowned for pioneering the use of stem cells in treating life-threatening diseases, including the discovery of pluripotent stem cells from the human placenta. His innovations have led to over 170 patents and numerous accolades, including the Pontifical Medal for Innovation and the Thomas Alva Edison Award.
He is an Adjunct Professor of Neurosurgery at Weill Cornell Medical College and serves on various prestigious boards, including the Liberty Science Center and the X PRIZE Foundation. Beyond his medical and scientific contributions, Dr. Hariri is an accomplished jet-rated pilot and film producer.
🎙 ABOUT JOHN MARCHICA, HOST OF HEALTH CARE ROUNDS:
John Marchica is a veteran health care strategist and CEO of Darwin Research Group, a strategic consulting and market intelligence firm focused on hospitals, health systems, physician groups, and the evolving health care ecosystem. John has a degree in economics from Knox College, an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.
CONNECT WITH US:
🌐 Follow Health Care Rounds on LinkedIn
🌐 Follow Darwin Research Group on LinkedIn
📺 Watch Health Care Rounds of YouTube⚙️ Health Care Rounds is produced by Grippi Media
174 episodi
Tutti gli episodi
×Benvenuto su Player FM!
Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.